EN HU

Division of Sports and Space Physiology

Division of Sports and Space Physiology
Division of Sports and Space Physiology
Uploaded publications:
25
Publications in DEA:
25
OA:
15
Date range:
2016-2025
2025
1.
Óvári, J., Kovács, Z. M., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Domingos, G. J., Fehér, Á., Varga, Z., Szentandrássy, N.: Delavirdine modifies action potential configuration via inhibition of IKr and Ito in canine ventricular myocytes.
Biomed. Pharmacother. 186, 1-13, (article identifier: 117994), 2025.
Journal metrics:
D1 Medicine (miscellaneous) (2024)
D1 Pharmacology (2024)
2024
2.
Kovács, Z. M., Horváth, B., Dienes, C., Óvári, J., Kiss, D. Z., Hézső, T., Szentandrássy, N., Magyar, J., Bányász, T., Nánási, P. P.: Beta-Adrenergic Activation of the Inward Rectifier K+ Current Is Mediated by the CaMKII Pathway in Canine Ventricular Cardiomyocytes.
Int. J. Mol. Sci. 25 (21), 1-14, (article identifier: 11609), 2024.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
3.
Kovács, Z. M., Óvári, J., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Fehér, Á., Varga, Z., Szentandrássy, N.: Correction: Kovács et al. ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr. Pharmaceuticals 2023, 16, 488.
Pharmaceuticals. 17 (9), 1-2, (article identifier: 1137), 2024.
4.
Horváth, B., Kovács, Z. M., Dienes, C., Barta, Z., Óvári, J., Szentandrássy, N., Magyar, J., Bányász, T., Nánási, P. P.: Relationship between ion currents and membrane capacitance in canine ventricular myocytes.
Sci. Rep. 14 (1), 11241, (article identifier: 11241), 2024.
Journal metrics:
Q1 Multidisciplinary
2023
5.
Kovács, Z. M., Óvári, J., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Fehér, Á., Varga, Z., Szentandrássy, N.: ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr.
Pharmaceuticals (Basel). 16 (4), 488, (article identifier: 488), 2023.
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
6.
Horváth, B., Kovács, Z. M., Dienes, C., Óvári, J., Szentandrássy, N., Magyar, J., Bányász, T., Varró, A., Nánási, P. P.: Conductance Changes of Na+ Channels during the Late Na+ Current Flowing under Action Potential Voltage Clamp Conditions in Canine, Rabbit, and Guinea Pig Ventricular Myocytes.
Pharmaceuticals (Basel). 16 (4), 560, (article identifier: 560), 2023.
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
7.
Naveed, M., Mohammed, A. S. A., Topal, L., Kovács, Z. M., Dienes, C., Óvári, J., Szentandrássy, N., Magyar, J., Bányász, T., Prorok, J., Jost, N., Virág, L., Baczkó, I., Varró, A., Nánási, P. P., Horváth, B.: Selective Inhibition of Cardiac Late Na+ Current Is Based on Fast Offset Kinetics of the Inhibitor.
Biomedicines. 11 (9), 2383, (article identifier: 2383), 2023.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1 Medicine (miscellaneous)
2022
8.
Gaál, Z., Fodor, J., Oláh, A., Radovits, T., Merkely, B., Magyar, J., Csernoch, L.: Evaluation of muscle-specific and metabolism regulating microRNAs in a chronic swimming rat model.
J. Muscle Res. Cell Motil. 43 (1), 21-33, 2022.
Journal metrics:
Q1 Biochemistry
Q2 Cell Biology
Q1 Physiology
9.
Kovács, Z. M., Dienes, C., Hézső, T., Almássy, J., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Szentandrássy, N.: Pharmacological Modulation and (Patho)Physiological Roles of TRPM4 Channel-Part 1: modulation of TRPM4.
Pharmaceuticals (Basel). 15 (1), 81, (article identifier: 81), 2022.
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
10.
Dienes, C., Kovács, Z. M., Hézső, T., Almássy, J., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Szentandrássy, N.: Pharmacological Modulation and (Patho)Physiological Roles of TRPM4 Channel-Part 2: TRPM4 in Health and Disease.
Pharmaceuticals (Basel). 15 (1), 40, (article identifier: 40), 2022.
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
2021
11.
Kiss, D. Z., Hézső, T., Dienes, C., Kovács, Z. M., Török, Z., Szentandrássy, N., Horváth, B., Bányász, T., Nánási, P. P., Magyar, J.: Calcium/calmodulin-dependent protein kinase II stimulates the inward rectifier potassium current in beta-adrenergic adaptation of ventricular cardiomyocytes.
Europace. 23 (Suppl.), iii634, 2021.
12.
Dienes, C., Hézső, T., Kiss, D. Z., Baranyai, D., Kovács, Z. M., Szabó, L., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Gönczi, M., Szentandrássy, N.: Electrophysiological Effects of the Transient Receptor Potential Melastatin 4 Channel Inhibitor (4-Chloro-2-(2-chlorophenoxy)acetamido) Benzoic Acid (CBA) in Canine Left Ventricular Cardiomyocytes.
Int. J. Mol. Sci. 22 (17), 9499, 2021.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
13.
Horváth, B., Kiss, D. Z., Dienes, C., Hézső, T., Kovács, Z. M., Szentandrássy, N., Almássy, J., Magyar, J., Bányász, T., Nánási, P. P.: Ion current profiles in canine ventricular myocytes obtained by the "onion peeling" technique.
J. Mol. Cell. Cardiol. 158, 153-162, 2021.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Q2 Molecular Biology
14.
Kiss, D. Z., Horváth, B., Hézső, T., Dienes, C., Kovács, Z. M., Topal, L., Szentandrássy, N., Almássy, J., Prorok, J., Virág, L., Bányász, T., Varró, A., Nánási, P. P., Magyar, J.: Late Na+ Current Is [Ca2+]i-Dependent in Canine Ventricular Myocytes.
Pharmaceuticals (Basel). 14 (11), 1142, 2021.
Journal metrics:
Q1 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
15.
Hézső, T., Naveed, M., Dienes, C., Kiss, D. Z., Prorok, J., Árpádffy-Lovas, T., Varga, R., Fujii, E., Mercan, T., Topal, L., Kistamás, K., Szentandrássy, N., Almássy, J., Jost, N., Magyar, J., Bányász, T., Baczkó, I., Varró, A., Nánási, P. P., Virág, L., Horváth, B.: Mexiletine-like cellular electrophysiological effects of GS967 in canine ventricular myocardium.
Sci. Rep. 11, 9565, 2021.
Journal metrics:
D1 Multidisciplinary
16.
Jost, N., Christ, T., Magyar, J.: New Strategies for the Treatment of Atrial Fibrillation.
Pharmaceuticals (Basel). 14 (9), 926, 2021.
Journal metrics:
Q1 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
2020
17.
Horváth, B., Hézső, T., Kiss, D. Z., Kistamás, K., Magyar, J., Nánási, P. P., Bányász, T.: Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents.
Front. Pharmacol. 11, 1-17, 2020.
Journal metrics:
Q1 Pharmacology
Q1 Pharmacology (medical)
18.
Horváth, B., Hézső, T., Szentandrássy, N., Kistamás, K., Árpádffy-Lovas, T., Varga, R., Gazdag, P., Veress, R., Dienes, C., Baranyai, D., Almássy, J., Virág, L., Nagy, N., Baczkó, I., Magyar, J., Bányász, T., Varró, A., Nánási, P. P.: Late sodium current in human, canine and guinea pig ventricular myocardium.
J. Mol. Cell. Cardiol. 139, 14-23, 2020.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Q2 Molecular Biology
19.
Kiss, D., Hézső, T., Kurtan, B., Veress, R., Baranyai, D., Kovács, Z., Dienes, C., Szentandrássy, N., Bányász, T., Magyar, J., Nánási, P. P., Horváth, B.: Regulation of the delayed rectifier potassium current during the adrenergic adaptation of cardiomyocytes.
Europace. 22 (Suppl_1), P938, 2020.
2018
20.
Horváth, B., Szentandrássy, N., Veress, R., Baranyai, D., Kistamás, K., Almássy, J., Tóth, A., Magyar, J., Bányász, T., Nánási, P. P.: Effect of the intracellular calcium concentration chelator BAPTA acetoxy-methylester on action potential duration in canine ventricular myocytes.
J. Physiol. Pharmacol. 69 (1), 99-107, 2018.
Journal metrics:
Q2 Medicine (miscellaneous)
Q2 Pharmacology
Q3 Physiology
21.
Veress, R., Baranyai, D., Hegyi, B., Kistamás, K., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Szentandrássy, N., Horváth, B.: Transient receptor potential melastatin 4 channel inhibitor 9-phenanthrol inhibits K+ but not Ca2+ currents in canine ventricular myocytes.
Can. J. Physiol. Pharmacol. 96 (10), 1022-1029, 2018.
Journal metrics:
Q2 Medicine (miscellaneous)
Q2 Pharmacology
Q3 Physiology
Q3 Physiology (medical)
2017
22.
Nánási, P. P., Magyar, J., Varró, A., Ördög, B.: Beat-to-beat variability of cardiac action potential duration: underlying mechanism and clinical implications.
Can. J. Physiol. Pharmacol. 95 (10), 1230-1235, 2017.
Journal metrics:
Q2 Medicine (miscellaneous)
Q2 Pharmacology
Q3 Physiology
Q3 Physiology (medical)
23.
Horváth, B., Szentandrássy, N., Veress, R., Almássy, J., Magyar, J., Bányász, T., Tóth, A., Papp, Z., Nánási, P. P.: Frequency-dependent effects of omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes.
Naunyn Schmiedebergs Arch. Pharmacol. 390 (2), 1239-1246, 2017.
Journal metrics:
Q2 Medicine (miscellaneous)
Q2 Pharmacology
2016
24.
Magyar, J., Kistamás, K., Váczi, K., Hegyi, B., Horváth, B., Bányász, T., Nánási, P. P., Szentandrássy, N.: Concept of relative variability of cardiac action potential duration and its test under various experimental conditions.
Gen. Physiol. Biophys. 35 (1), 55-62, 2016.
Journal metrics:
Q3 Biophysics
Q3 Medicine (miscellaneous)
Q4 Physiology
25.
Szentandrássy, N., Horváth, B., Váczi, K., Kistamás, K., Masuda, L., Magyar, J., Bányász, T., Papp, Z., Nánási, P. P.: Dose-dependent electrophysiological effects of the myosin activator omecamtiv mecarbil in canine ventricular cardiomyocytes.
J. Physiol. Pharmacol. 67 (4), 483-489, 2016.
Journal metrics:
Q1 Medicine (miscellaneous)
Q2 Pharmacology
Q2 Physiology
DEENK University of Debrecen
© 2012 University of Debrecen